Does Non-Surgical Periodontal Therapy in Overweight and Obesity Result in a Change in Body Mass Index? A Review of Current Evidence

Clinical Advances in Periodontics
Maria L GeisingerMichael S Reddy

Abstract

Focused Clinical Question In patients with chronic periodontitis (CP) classified as overweight or obese who receive non-surgical periodontal therapy, is a change in body mass index (BMI) associated with periodontal treatment? Clinical Scenario A 47-year-old male presents to your office with a chief complaint of "I was told I have periodontal disease." He is missing tooth #9 and has significant supragingival and subgingival calculus deposits (Fig. 1). After examination, you assign a diagnosis of generalized moderate to severe CP. His probing depths (PDs) range from 2 to 8 mm, and his clinical attachment levels range from 2 to 8 mm, with 56% of sites demonstrating PD ≥4 mm. His medical history is significant for hypertension, osteoarthritis, gastroesophageal reflux disease, and obesity, with a current BMI of 31 kg/m2. He reports taking 5 mg enalapril every day, ibuprofen as needed for pain, and 20 mg omeprazole every day. Your treatment plan includes non-surgical therapy and periodontal reevaluation before possible phase II surgical treatment. The patient states that he recently read an article in lay media discussing the link between obesity and periodontal disease and is interested in optimizing his health.

References

Oct 13, 2001·Journal of Dental Research·T SaitoA Ohshima
Jun 21, 2003·Journal of Periodontology·Mohammad S Al-ZahraniElaine A Borawskit
Oct 15, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·G A Bray
Jun 23, 2006·The Lancet Infectious Diseases·Matthew E Falagas, Maria Kompoti
Aug 11, 2006·Journal of Clinical Periodontology·P P HujoelN R Kressin
Feb 24, 2007·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·P Kopelman
Apr 4, 2007·Journal of Clinical Periodontology·Gerry LindenFrank Kee
Apr 25, 2007·Journal of Dental Research·N PischonT Pischon
May 4, 2007·Periodontology 2000·Christine Seel Ritchie
Jul 21, 2007·Southern Medical Journal·S Gul OzTumay Sozen
Apr 3, 2008·Mayo Clinic Proceedings·John K DiBaiseBruce E Rittmann
Dec 2, 2008·Nature·Peter J TurnbaughJeffrey I Gordon
Feb 12, 2009·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·F BoesingE A M Moreira
Jul 10, 2009·Journal of Dental Research·P BullonM Battino
Sep 10, 2009·Australian Dental Journal·M P CullinanG J Seymour
Apr 24, 2010·Oral Diseases·O FentoğluF Y Kirzioğlu
Aug 21, 2010·Journal of Periodontology·Benjamin W Chaffee, Scott J Weston
Nov 16, 2010·Journal of Periodontology·Elizangela P ZuzaBenedicto Egbert C Toledo
Feb 26, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Jean SuvanNikos Donos
Oct 14, 2011·Journal of Clinical Gastroenterology·Harry J Flint
Dec 14, 2011·Journal of Clinical Periodontology·Andrea GormanRaul I Garcia
Sep 1, 2012·Journal of Dental Research·P I EkeR J Genco
May 3, 2013·Journal of Periodontology·Iain L C ChappleUNKNOWN working group 2 of the joint EFP/AAP workshop

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.